Global Human Microbiome Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Human Microbiome Market is expected to grow from USD 614.58 Million in 2018 to USD 2,506.87 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 22.24%.
The positioning of the Global Human Microbiome Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market including are DuPont, E.I. Du Pont De Nemours and Company, Enterome Bioscience, Merck & Co., Inc., Metabiomics Corporation, Microbiome Therapeutics, LLC, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synlogic Inc., Synthetic Biologics Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals, and Yakult Honsha Co., Ltd..
On the basis of Technology, the Global Human Microbiome Market is studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology.
On the basis of Therapeutic Area, the Global Human Microbiome Market is studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health.
On the basis of Product, the Global Human Microbiome Market is studied across Diagnostic Devices, Drugs, Foods, Medical Foods, Prebiotics, and Probiotics.
On the basis of Disease, the Global Human Microbiome Market is studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity.
On the basis of Application, the Global Human Microbiome Market is studied across Diagnostics and Therapeutics.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Human Microbiome Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Human Microbiome Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Human Microbiome Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Human Microbiome Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Human Microbiome Market
The report answers questions such as:
1. What is the market size of Human Microbiome market in the Global?
2. What are the factors that affect the growth in the Global Human Microbiome Market over the forecast period?
3. What is the competitive position in the Global Human Microbiome Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Human Microbiome Market?
5. What are the opportunities in the Global Human Microbiome Market?
6. What are the modes of entering the Global Human Microbiome Market?
The positioning of the Global Human Microbiome Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market including are DuPont, E.I. Du Pont De Nemours and Company, Enterome Bioscience, Merck & Co., Inc., Metabiomics Corporation, Microbiome Therapeutics, LLC, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synlogic Inc., Synthetic Biologics Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals, and Yakult Honsha Co., Ltd..
On the basis of Technology, the Global Human Microbiome Market is studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology.
On the basis of Therapeutic Area, the Global Human Microbiome Market is studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health.
On the basis of Product, the Global Human Microbiome Market is studied across Diagnostic Devices, Drugs, Foods, Medical Foods, Prebiotics, and Probiotics.
On the basis of Disease, the Global Human Microbiome Market is studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity.
On the basis of Application, the Global Human Microbiome Market is studied across Diagnostics and Therapeutics.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Human Microbiome Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Human Microbiome Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Human Microbiome Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Human Microbiome Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Human Microbiome Market
The report answers questions such as:
1. What is the market size of Human Microbiome market in the Global?
2. What are the factors that affect the growth in the Global Human Microbiome Market over the forecast period?
3. What is the competitive position in the Global Human Microbiome Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Human Microbiome Market?
5. What are the opportunities in the Global Human Microbiome Market?
6. What are the modes of entering the Global Human Microbiome Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Human Microbiome Market
3.2. Opportunities in the Human Microbiome Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increased focus on human microbiome therapy
4.2.1.2. Human microbiome for drug development, early disease detection, and diagnosis
4.2.2. Restraints
4.2.2.1. Limited expertise and lack of comprehensive research
4.2.3. Opportunities
4.2.3.1. Increasing collaborations and research investments to create growth opportunities
4.2.3.2. Development of human microbiome therapeutic products
4.2.4. Challenges
4.2.4.1. Causal links between microbiota dysbiosis and disease
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Regulatory Framework
4.4.2. Patent & Funding
4.4.3. Impact of Human Microbiome Therapeutics on Current Treatment Options
5. GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. 16s rRNA Sequencing
5.4. Cell Culture Technology
5.5. Computational Tools
5.6. High-Throughput Technology
5.7. Metagenomic Sequencing
5.8. Omics Technology
6. GLOBAL HUMAN MICROBIOME MARKET, BY THERAPEUTIC AREA
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Gastrointestinal Disorders
6.4. Metabolic Disorders
6.5. Skin Disorders
6.6. Women’s Health
7. GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Diagnostic Devices
7.4. Drugs
7.5. Foods
7.6. Medical Foods
7.7. Prebiotics
7.8. Probiotics
8. GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Acute Diarrhea
8.4. Autoimmune Disorders
8.5. Cancer
8.6. Diabetes
8.7. Mental Disorders
8.8. Obesity
9. GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Diagnostics
9.4. Therapeutics
10. GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. Americas
10.3.1. Overview
10.3.2. Market Sizing & Forecasting
10.3.3. Argentina
10.3.4. Brazil
10.3.5. Canada
10.3.6. Mexico
10.3.7. United States
10.4. Asia-Pacific
10.4.1. Overview
10.4.2. Market Sizing & Forecasting
10.4.3. Australia
10.4.4. China
10.4.5. India
10.4.6. Japan
10.5. Europe, Middle East & Africa
10.5.1. Overview
10.5.2. Market Sizing & Forecasting
10.5.3. France
10.5.4. Germany
10.5.5. Italy
10.5.6. Spain
10.5.7. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. 360iResearch FPNV Positioning Matrix for Global Human Microbiome Market
11.2. Market Vendor Ranking Analysis for Global Human Microbiome Market
11.3. Competitive News Feed Analysis for Global Human Microbiome Market
12. COMPANY USABILITY PROFILES
12.1. DuPont
12.1.1. Overview
12.1.2. Strategy
12.1.3. SWOT
12.2. E.I. Du Pont De Nemours and Company
12.2.1. Overview
12.2.2. Strategy
12.2.3. SWOT
12.3. Enterome Bioscience
12.3.1. Overview
12.3.2. Strategy
12.3.3. SWOT
12.4. Merck & Co., Inc.
12.4.1. Overview
12.4.2. Strategy
12.4.3. SWOT
12.5. Metabiomics Corporation
12.5.1. Overview
12.5.2. Strategy
12.5.3. SWOT
12.6. Microbiome Therapeutics, LLC
12.7. Osel, Inc.
12.8. Second Genome, Inc.
12.9. Seres Therapeutics
12.10. Synlogic Inc.
12.11. Synthetic Biologics Inc.
12.12. Vedanta Biosciences, Inc.
12.13. Vithera Pharmaceuticals
12.14. Yakult Honsha Co., Ltd.
13. APPENDIX
13.1. Discussion Guide
13.2. Top Reports
13.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Human Microbiome Market
3.2. Opportunities in the Human Microbiome Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increased focus on human microbiome therapy
4.2.1.2. Human microbiome for drug development, early disease detection, and diagnosis
4.2.2. Restraints
4.2.2.1. Limited expertise and lack of comprehensive research
4.2.3. Opportunities
4.2.3.1. Increasing collaborations and research investments to create growth opportunities
4.2.3.2. Development of human microbiome therapeutic products
4.2.4. Challenges
4.2.4.1. Causal links between microbiota dysbiosis and disease
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Regulatory Framework
4.4.2. Patent & Funding
4.4.3. Impact of Human Microbiome Therapeutics on Current Treatment Options
5. GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. 16s rRNA Sequencing
5.4. Cell Culture Technology
5.5. Computational Tools
5.6. High-Throughput Technology
5.7. Metagenomic Sequencing
5.8. Omics Technology
6. GLOBAL HUMAN MICROBIOME MARKET, BY THERAPEUTIC AREA
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Gastrointestinal Disorders
6.4. Metabolic Disorders
6.5. Skin Disorders
6.6. Women’s Health
7. GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Diagnostic Devices
7.4. Drugs
7.5. Foods
7.6. Medical Foods
7.7. Prebiotics
7.8. Probiotics
8. GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Acute Diarrhea
8.4. Autoimmune Disorders
8.5. Cancer
8.6. Diabetes
8.7. Mental Disorders
8.8. Obesity
9. GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Diagnostics
9.4. Therapeutics
10. GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. Americas
10.3.1. Overview
10.3.2. Market Sizing & Forecasting
10.3.3. Argentina
10.3.4. Brazil
10.3.5. Canada
10.3.6. Mexico
10.3.7. United States
10.4. Asia-Pacific
10.4.1. Overview
10.4.2. Market Sizing & Forecasting
10.4.3. Australia
10.4.4. China
10.4.5. India
10.4.6. Japan
10.5. Europe, Middle East & Africa
10.5.1. Overview
10.5.2. Market Sizing & Forecasting
10.5.3. France
10.5.4. Germany
10.5.5. Italy
10.5.6. Spain
10.5.7. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. 360iResearch FPNV Positioning Matrix for Global Human Microbiome Market
11.2. Market Vendor Ranking Analysis for Global Human Microbiome Market
11.3. Competitive News Feed Analysis for Global Human Microbiome Market
12. COMPANY USABILITY PROFILES
12.1. DuPont
12.1.1. Overview
12.1.2. Strategy
12.1.3. SWOT
12.2. E.I. Du Pont De Nemours and Company
12.2.1. Overview
12.2.2. Strategy
12.2.3. SWOT
12.3. Enterome Bioscience
12.3.1. Overview
12.3.2. Strategy
12.3.3. SWOT
12.4. Merck & Co., Inc.
12.4.1. Overview
12.4.2. Strategy
12.4.3. SWOT
12.5. Metabiomics Corporation
12.5.1. Overview
12.5.2. Strategy
12.5.3. SWOT
12.6. Microbiome Therapeutics, LLC
12.7. Osel, Inc.
12.8. Second Genome, Inc.
12.9. Seres Therapeutics
12.10. Synlogic Inc.
12.11. Synthetic Biologics Inc.
12.12. Vedanta Biosciences, Inc.
12.13. Vithera Pharmaceuticals
12.14. Yakult Honsha Co., Ltd.
13. APPENDIX
13.1. Discussion Guide
13.2. Top Reports
13.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.3. Author Details
